Clinical Trials in Hangzhou, China
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell CarcinomaNeoadjuvant Treatment
Second Affiliated Hospital, School of Medicine, Zhejiang University35 enrolled1 locationNCT06576973
Recruiting
Phase 1
Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Second Affiliated Hospital, School of Medicine, Zhejiang University10 enrolled1 locationNCT06421701
Recruiting
Phase 1
Human Leukocyte Antigen (HLA) Mismatched Related Allogeneic Hematopoietic Stem Cell Transplantation
Hematologic Diseases
He Huang29 enrolled1 locationNCT06809699